- January 10th, 2025
- Category: press
Paul Mauhin appointed Chief Financial Officer of radiomics.bio, succeeding Mathieu Delvaux
A warm farewell and new beginnings, Mathieu Delveaux passes the baton to newly appointed CFO, Paul Mauhin.
Press Release
Paul Mauhin appointed Chief Financial Officer of radiomics.bio, succeeding Mathieu Delveaux.
A warm farewell and new beginnings, Mathieu Delveaux passes the baton to newly appointed CFO, Paul Mauhin
Liège, Belgium, 10/01/2025 – Paul Mauhin joins the radiomics.bio team as Chief Financial Officer as Mathieu Delveaux steps down after 5 fruitful years to further develop other promising ventures and continue his entrepreneurial journey at Altesia.
“It has been a pleasure to accompany the company from a start up to the scale-up that it is today. As I continue to follow radiomics.bio but this time from afar, I wish the team the best and look forward to seeing how they will continue to develop and make a difference in the cancer research space,” shared Mathieu Delveaux.
Chief Executive Officer of radiomics.bio, Wim Vos stated,
We will certainly miss Mathieu, both personally and professionally. His personality and skillset have been instrumental to achieving our current status and we are very lucky to have shared this part of the voyage with him over the last 5 years. We wish him the best in his new endeavours and have no doubt he will continue to do great things.”
Mathieu now passes the reigns to Paul Mauhin, an accomplished financial executive with extensive expertise in both the biotech and industrial technology sectors. Holding a master’s degree from HEC Liège, he brings a robust background in financial management and strategic operations, consistently demonstrated by his leadership in guiding companies through critical growth phases.
The newly appointed CFO shared, “Firstly, I’d like to extend my gratitude to the team at radiomics.bio for their warm welcome and particularly to Mathieu who created an ideal environment for a seamless transition. I am very excited to join radiomics.bio as the company propels into a new chapter and I am very much looking forward to playing a part in the success story of radiomics.bio.”
About radiomics.bio
radiomics.bio is an AI-powered medical imaging and advanced statistics clinical research organisation, optimising the development of new oncology treatments.
![[:swvar:ufile:1:description:]](/swfiles/files/logo-radiomics.svg?nc=1736500828){kind=logo}